P1211: TUMOR-ACTIVATED LYMPH NODE FIBROBLASTS SUPPRESS T CELL FUNCTION IN DIFFUSE LARGE B CELL LYMPHOMA

• Benedetta Apollonio,
• Filomena Spada,
• Nedyalko Petrov,
• Domenico Cozzetto,
• Peter Jarvis,
• Despoina Papazoglou,
• Shichina Kannambath,
• Manuela Terranova-Barberio,
• Rose-Marie Amini,
• Gunilla Enblad,
• Charlotte Graham,
• Reuben Benjamin,
• Elizabeth H. Phillips,
• Richard Ellis,
• Rosamond Nuamah,
• Mansoor Saqi,
• Dinis Calado,
• Richard Rosenquist,
• Lesley Ann Sutton,
• Jon Salisbury,
• Georgios Zacharioudakis,
• Anna Vardi,
• Patrick Hagner,
• Anita Gandhi,
• Marina Bacac,
• Christina Claus,
• Pablo Umana,
• Ruth Jarrett,
• Christian Klein,
• Alexander Deutsch,
• Alan Ramsay

Affiliations

Benedetta Apollonio

1 King’s College London, School of Cancer and Pharmaceutical Sciences, London, United Kingdom

Filomena Spada

2 Guy’s and St. Thomas’s NHS Foundation Trust and King’s College London, BRC Advanced Cytometry Platform, London, United Kingdom

Nedyalko Petrov

2 Guy’s and St. Thomas’s NHS Foundation Trust and King’s College London, BRC Advanced Cytometry Platform, London, United Kingdom

Domenico Cozzetto

3 Imperial College London, Division of Digestive Diseases, London, United Kingdom

Peter Jarvis

1 King’s College London, School of Cancer and Pharmaceutical Sciences, London, United Kingdom

Despoina Papazoglou

1 King’s College London, School of Cancer and Pharmaceutical Sciences, London, United Kingdom

Shichina Kannambath

4 Guy’s and St. Thomas’s NHS Foundation Trust and King’s College London, BRC Genomics Research Platform, London, United Kingdom

Manuela Terranova-Barberio

2 Guy’s and St. Thomas’s NHS Foundation Trust and King’s College London, BRC Advanced Cytometry Platform, London, United Kingdom

Rose-Marie Amini

5 Uppsala University and Hospital, Department of Immunology, Genetics and Pathology, Uppsala, Sweden

Gunilla Enblad

5 Uppsala University and Hospital, Department of Immunology, Genetics and Pathology, Uppsala, Sweden

Charlotte Graham

1 King’s College London, School of Cancer and Pharmaceutical Sciences, London, United Kingdom

Reuben Benjamin

1 King’s College London, School of Cancer and Pharmaceutical Sciences, London, United Kingdom

Elizabeth H. Phillips

1 King’s College London, School of Cancer and Pharmaceutical Sciences, London, United Kingdom

Richard Ellis

2 Guy’s and St. Thomas’s NHS Foundation Trust and King’s College London, BRC Advanced Cytometry Platform, London, United Kingdom

Rosamond Nuamah

4 Guy’s and St. Thomas’s NHS Foundation Trust and King’s College London, BRC Genomics Research Platform, London, United Kingdom

Mansoor Saqi

6 Guy’s and St. Thomas’s NHS Foundation Trust and King’s College London, BRC Translational Bioinformatics, London, United Kingdom

Dinis Calado

7 Francis Crick Institute, Immunity & Cancer Laboratory, London, United Kingdom

Richard Rosenquist

8 Karolinska Institutet, Department of Molecular Medicine and Surgery, Stockholm, Sweden

Lesley Ann Sutton

8 Karolinska Institutet, Department of Molecular Medicine and Surgery, Stockholm, Sweden

Jon Salisbury

9 King’s College Hospital NHS Foundation Trust, London, United Kingdom

Georgios Zacharioudakis

10 Aristotle University of Thessaloniki, Thessaloniki, Greece

Anna Vardi

11 G. Papanikolaou Hospital, Hematology Department and HCT Unit, Thessaloniki, Greece

Patrick Hagner

12 Bristol-Myers Squibb, Summit, United States

Anita Gandhi

12 Bristol-Myers Squibb, Summit, United States

Marina Bacac

13 Roche Innovation Center Zurich, Zurich, Switzerland

Christina Claus

13 Roche Innovation Center Zurich, Zurich, Switzerland

Pablo Umana

13 Roche Innovation Center Zurich, Zurich, Switzerland

Ruth Jarrett

14 MRC-University of Glasgow Centre for Virus Research, Glasgow, United Kingdom

Christian Klein

13 Roche Innovation Center Zurich, Zurich, Switzerland

Alexander Deutsch

15 Medical University of Graz, Graz, Austria

Alan Ramsay

1 King’s College London, School of Cancer and Pharmaceutical Sciences, London, United Kingdom